AstraZeneca launches a $1.5 billion annual savings plan to invest in drug development
AstraZeneca announced a new program aiming for annual savings of $1.5 billion. The company said it expects to reach $80 billion in annual revenue by 2030. It reported a 23-percent jump in net profit for the third quarter.
- AstraZeneca announced a new program aiming for annual savings of $1.5 billion.
- AstraZeneca stated it expects to reach $80 billion in group annual revenue by 2030.
- AstraZeneca announced a 23-percent jump in net profit for the third quarter.
Outlets: Channels TV, Euronews (FR), Free Malaysia Today, RTL Today, TelQuel
Written by AI from the outlets' reporting and checked automatically; it can contain mistakes. How Daily Brief works · Privacy